Session: Influenza Vaccines (IDWeek 2012 Meeting)

Saturday, October 20, 2012: 12:30 PM-2:00 PM

Room: SDCC Poster Hall F-H

Topical Category: I. Adult and Pediatric Vaccines and P. Pediatric and Perinatal Infections

Tracks: Adult ID, Pediatric ID

Presentations:

1503	Pregnancy Modifies the Antibody Response to Trivalent Influenza Immunization Elizabeth P. Schlaudecker, M.D., M.P.H. ; Monica McNeal, MS ; Caitlin Dodd, M.S. ; Joseph Ranz, B.S. ; Mark C. Steinhoff, M.D. Posters IDWeek Procter poster 10.1.12.pdf (103.0 kB)

1504	Influenza in Infants Born to Women Reporting Influenza Immunization During Pregnancy Julie Shakib, DO, MPH, MSCI ; Kent Korgenski, MS ; Andrew Pavia, MD, FIDSA, FSHEA ; Carrie L. Byington, MD

1506

Safety Assessment of MF-59 Adjuvanted Influenza Vaccine During Pregnancy
Daniel Stecher, Physician ; Emanuel Godoy, Resident ; Victoria Iannantuonno, Resident ; Vanesa Fridman, Physician ; Andrea Padovani, Physician ; Hilda Ruda Vega, Physician ; María Beatriz Lasala, Physician

Posters

Safety Assessment of MF-59 Adjuvanted Influenza Vaccine During Pregnancy.pdf (296.4 kB)

1507	Effects of Attitudes, Knowledge, and Provider Recommendation on Uptake of the Influenza Vaccine During Pregnancy Hamzah Moh'd, MD Posters Poster.pdf (377.3 kB)

1508

Breast Milk Antibody and Neutralization Activity at One Year Postpartum after Antenatal Influenza Immunization
Mark Steinhoff, MD, FIDSA ; Elizabeth P. Schlaudecker, M.D., M.P.H. ; Saad B. Omer, MBBS, MPH, PhD ; Monica McNeal, MS ; Eliza Roy, DCH ; Shams E. Arifeen, MBBS, DrPH ; Caitlin Dodd, M.S. ; Rubhana Raqib, PhD ; Robert Breiman, MD ; Khalequ Zaman, MBBS, PhD

1509	B-cell Response to Trivalent Inactivated versus Live-Attenuated Influenza Vaccines in Identical Twin Children Kareem Shehab, MD ; Sanae Sasaki, PhD ; Cornelia L. Dekker, MD ; Xiao-Song He, PhD ; Harry Greenberg, MD

1510

Immunogenicity and Safety Profile of an AS03-Adjuvanted H5N1 Vaccine in Children 6 Months to <18 Years of Age: a Randomized Multi-center Trial
Pope Kosalaraksa, MD. ; Robert Jeanfreau, MD ; Louise Frenette, MD ; Mamadou Dramé, MSc ; Miguel Madariaga, MD, MSc ; Olivier Godeaux, MD ; Patricia Izurieta, MD, Ph.D ; David Vaughn, MD, MPH

1511	Cost-effectiveness of Live Attenuated Influenza Vaccine Versus Inactivated Influenza Vaccine among Children Aged 2-17 Years for Mild, Moderate and Severe Influenza Seasons Kellie Ryan, MPH ; Timothy Klein ; Christopher Bly ; Lee Smolen Posters 1511 HOPE P514 P515 Poster.pdf (320.2 kB)

1512	Effectiveness of Self-Administration of Intranasal Live Attenuated Influenza Vaccine in Adults Christopher Ambrose, MD ; Xionghua Wu, PhD Posters FLU12015.3149.pdf (195.2 kB)

1513

The Safety and Immunogenicity of High Dose Trivalent Influenza Vaccine (TIV) Compared to Standard Dose TIV in Pediatric Solid Organ Transplant (SOT) Patients
Sarah Rich, MD ; Marian Michaels, MD, MPH ; Jonathan A. McCullers, MD ; Wenli Wang, MS ; Steve Ampah, MS ; Alice O'Shea, RN ; Michael Green, MD, MPH ; Natasha Halasa, MD MPH

Posters

IDSA_poster SOT FINAL OCT 2012.pdf (84.4 kB)

1514

Trivalent Inactivated Influenza Vaccine (TIV) and Live Attenuated Influenza Vaccine (LAIV) Induce Different B cell Responses in Blood of Immunized Children
Raquel Giacomelli Cao, MD ; Santiago M.C. López, MD ; Emilio Flaño, PhD ; Gerlinde Obermoser, MD ; Sara Mertz, BS ; Shelli Farley ; Paulla Davies ; Adolfo Garcia-Sastre, PhD ; Randy Albrecht, PhD ; Asuncion Mejias, MD, PhD ; Octavio Ramilo, MD

Posters

RIS-RC-625_IDSA_RC_final.pdf (1.2 MB)

1515

The Safety and Immunogenicity of High Dose Trivalent Influenza Vaccine (TIV) Compared to Standard Dose TIV in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients
Meghann McManus, D.O. ; Haydar Frangoul, M.D. ; Jonathan A. McCullers, MD ; Wenli Wang, MS ; Steve Ampah, MS ; Alice O'Shea, RN ; Natasha Halasa, MD MPH

Posters

FINAL ALL IDSA POSTER 10 15 2012.pdf (232.8 kB)

1516

Immunogenicity and Safety of FluzoneHD, a High-Dose Influenza Vaccine, versus Fluzone, a Standard-Dose Influenza Vaccine in Children with Cancer or HIV: a Randomized, Open-label, Clinical Trial
Hana Hakim, MD, MS ; Kim J. Allison, BSN ; Lee-Ann Van De Velde, BBiomedSc(Hons) ; Amy Iverson, BS ; Patricia M. Flynn, MD, MS ; Jonathan A. McCullers, MD

1517	Possible Impact of the Yearly childhood Vaccinations with Trivalent Influenza Vaccine (TIV) on the Immune Response to Pandemic Strain H1N1 Ahdi Amer, MD ; Howard Fischer, MD ; Basim Asmar, MD ; Muhammad Bilal, MD ; Priyanka Nanjireddy, MBBS Posters H1N1 Poster PDF.pdf (45.9 kB)

1518	Influenza Vaccine Effectiveness in Households with Children Joshua G. Petrie, MPH ; Suzanne E. Ohmit, DrPH ; Ryan E. Malosh, MPH ; Arnold Monto, MD

1519	The Role of Nasal Secretory IgA in Children Vaccinated With Live Attenuated Influenza Vaccine Christopher Ambrose, MD ; Xionghua Wu, PhD ; Taff Jones, PhD ; Raburn Mallory, MD Posters FLU12015.3148.pdf (176.4 kB)

1520	Automated Screening of Hospitalized Children for Influenza Vaccination Ari Pollack, MD, MA ; Matthew Kronman, MD, MSCE ; Danielle Zerr, MD, MPH

1521

School-Located Influenza Vaccinations Decrease Laboratory-Confirmed Influenza Rates and Improves School Attendance
Pia Pannaraj, MD, MPH ; Alvin Nelson El Amin, MD, MPH ; Hailin Wang, MPH ; Chrysanthy Ha, MPH ; Hector Rivas ; Michael Smit, MD, MSPH ; Grace Aldrovandi, MD ; Laurene Mascola, MD, MPH

Posters

Pannaraj.IDSAPosterFinal10 2012.pdf (192.4 kB)

1522	Improving Influenza Immunization Rates in Children with Diabetes Angela Myers, MD, MPH ; David Williams, MPH ; Joseph Cernich, MD ; Arthur Williams, PhD, MA(Econ), MPA ; Mary Anne Jackson, MD, FIDSA Posters Influenza-Diabetes_IDSA_Poster_FINAL.pdf (468.0 kB)

1523	Immunogenicity and Safety Profile of an AS03-adjuvanted H5N1 Influenza Vaccine Prepared from 4-year-old Stockpiled Bulk Antigen Patricia Izurieta, MD, Ph.D ; Mamadou Dramé, MSc ; Miguel Madariaga, MD, MSc ; Olivier Godeaux, MD ; David Vaughn, MD, MPH

1524

Evaluation of the Neuraminidase-Inhibiting Antibody Response to Inactivated Influenza Vaccine by Enzyme-Linked Lectin Assay
Maryrose Laguio, MD ; Mark Thompson, Ph. D ; Manjusha Gaglani, MBBS ; Allison Naleway, PhD ; Sarah Spencer, Ph.D ; Sarah Ball, MPH, ScD ; Steven Baker, B.S., M.S. ; Luis Martinez-Sobrido, Ph.D. ; David Shay, MD, MPH ; John J. Treanor, MD

1525

Seasonal and Pandemic Vaccine Effectiveness in the Prevention of Influenza-related Hospitalization in Canadian Adults
Shelly McNeil, MD ; Allison McGeer, MD, FSHEA ; Karen Green, MSc ; Ardith Ambrose, RN ; Jennie Johnstone, MD ; Todd Hatchette, MD ; Jason LeBlanc, PhD ; Duncan Webster, MD ; Mark Loeb, MD ; Anne McCarthy, MD, MSc ; Guy Boivin, MD ; Sylvie Trottier, MD ; Christina Wang ; Melissa Andrew, MD, PhD ; Louis Valiquette, MD ; Grant Stiver, MD

Posters

McNeil_SOS_Influenza_VE_IDSA_2012[1][1]PDF.pdf (359.8 kB)

1526

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate versus Two Trivalent Influenza Vaccines: a Randomized Controlled Trial in Adults
Juan Carlos Tinoco, MD ; Noris Pavia-Ruz, MD, MSc ; Aurelio Cruz-Valdez, PhD ; Carlos Aranza Doniz, MD ; Vijayalakshmi Chandrasekaran, MSc ; Walthère Dewé, MSc ; Aixue Liu, MD, PhD ; Bruce L. Innis, MD ; Varsha K. Jain, MD, MPH

1527	Safety and Immunogenicity Comparison of 2011-2012 High-Dose and Standard Intramuscular Influenza Vaccines in Older Adults Corwin A. Robertson, MD, MPH ; David P. Greenberg, MD, FIDSA ; Michael D. Decker, MD, MPH Posters Abstract_1527.pdf (708.2 kB)

1529

Evaluation of a Standardized Measure for Reporting Healthcare Personnel Influenza Vaccination Data, 2010-2011
Megan C. Lindley, MPH ; Faruque Ahmed, PhD ; Suchita Lorick, DO ; Tara MacCannell, PhD ; Anita Geevarughese, MD, MPH ; Robert Harrison, MD, MPH ; David Nace, MD, MPH ; Carmela Smith, MS

Posters

12_CS_234876_INFLUENZA VACCINATION POSTER.pdf (1.5 MB)

1530

Healthcare Workers’ (HCWs) Reasons For and Against Recommending Influenza Vaccination during the 2010-2011 Influenza Season – Maricopa County, Arizona
Bianca Salas, BIS ; Vjollca Berisha, MD, MPH ; Andrean Bunko Patterson, MPH ; Tammy Sylvester, RN, BSN ; Jennifer Stewart, MS

Posters

IDWeek Poster_Vaccine Recommendations.pdf (335.8 kB)

CME Credits:

See more of: Poster Abstract Session

<< Previous Session | Next Session >>